EL PAPEL DE LOS MODIFICADORES DE LEUCOTRIENOS EN EL TRATAMIENTO DEL ASMA INDUCIDA POR ASPIRINA
Columnista Experto de SIIC Yasushi Obase
en colaboración con
Matsusex Hiroto, MD, PhD, Hiroto Nagasaki University School of Medicine; Shimoda Terufumi, MD, PhD, Clinical Research Center, National Minami Fukuoka Hospital; Kohno Shigeru, MD, PhD, Nagasaki University School of Medicine
Fecha de aprobación: 29 de agosto, 2003
Primera edición en siicsalud:
6 de octubre, 2003
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/20093
Especialidad principal:
Alergia
Especialidades relacionadas:
Farmacología,Inmunología,Medicina Interna,Neumonología,
Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma, Clin Pharmacol Ther. 73(73):469-74, 2003
Obase Y, Shimoda T, Kawano T, Saeki S, Tomari S, Izaki K, Fukushima C, Matsuse H, Kohno S. Bronchial hyperresponsiveness and airway inflammation in adolescents with asymptomatic childhood asthma, Journal Allergy 58(58):213-20, 2003
Obase Y, Shimoda T, Tomari S, Mitsuta K, Kawano T, Matsuse H and Kohno S. Effects of pranlukast on chemical mediators in induced-sputum on provocation test in atopic and aspirin-intolerant asthmatics, Chest 121(121):143-50, 2002
Matsuse H, Shimoda T, Fukushima C, Mitsuta K, Kawano T, Tomari S, Saeki S, Kondoh Y, Machida I, Obase Y, Asai S and Kohno S. Screening for acetaldehyde dehydrogenase 2 genotype in alcohol-induced asthma by using the ethanol patch test, J Allergy Clin Immunol. 108(108):715-9, 2001
Tomari S, Shimoda T, Kawano T, Mitsuta K, Obase Y, Fukushima C, Matsuse H and Kohno S. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma, Ann Allergy Asthma Immunol. 87(87):156-61, 2001
Obase Y, Shimoda T, Tomari S, Mitsuta K, Fukushima C, Kawano T, Matsuse H and Kohno S. Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients, Ann Allergy Asthma Immunol. 87(87):74-9, 2001
Obase Y, Shimoda T, Tomari S, Mitsuta K, Fukushima C, Kawano T, Matsuse H and Kohno S. Efficacy and safety of long-term treatment of asthmatic patients with pranlukast cysteinyl-leukotriene-receptor antagonist: four-year followup study, Ann Allergy Asthma Immunol 87(87):43-7, 2001
Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H and Kohno S. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum, Ann Allergy Asthma Immunol. 86(86):304-10, 2001
Yasushi Obase
